Annual EBIT
-$31.92 M
-$11.99 M-60.20%
31 December 2023
Summary:
AIM ImmunoTech annual earnings before interest & taxes is currently -$31.92 million, with the most recent change of -$11.99 million (-60.20%) on 31 December 2023. During the last 3 years, it has fallen by -$12.86 million (-67.45%). AIM annual EBIT is now -3091.60% below its all-time high of $2.07 million.AIM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$3.50 M
-$1.84 M-111.10%
30 September 2024
Summary:
AIM ImmunoTech quarterly earnings before interest & taxes is currently -$3.50 million, with the most recent change of -$1.84 million (-111.10%) on 30 September 2024. Over the past year, it has increased by +$12.03 million (+77.48%). AIM quarterly EBIT is now -599.71% below its all-time high of $700.00 thousand, reached on 31 March 1995.AIM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$26.43 M
+$4.32 M+14.04%
30 September 2024
Summary:
AIM ImmunoTech TTM earnings before interest & taxes is currently -$26.43 million, with the most recent change of +$4.32 million (+14.04%) on 30 September 2024. Over the past year, it has increased by +$5.49 million (+17.19%). AIM TTM EBIT is now -1358.57% below its all-time high of $2.10 million, reached on 30 September 1995.AIM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +77.5% | +17.2% |
| 3 y3 years | -67.5% | +40.2% | -38.8% |
| 5 y5 years | -255.5% | -198.2% | -194.2% |
AIM EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -132.5% | at low | -111.1% | +77.5% | -54.8% | +22.3% |
| 5 y | 5 years | -255.5% | at low | -198.2% | +77.5% | -194.2% | +22.3% |
| alltime | all time | -3091.6% | at low | -599.7% | +77.5% | -1358.6% | +22.3% |
AIM ImmunoTech EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.50 M(+111.1%) | -$26.43 M(-14.0%) |
| June 2024 | - | -$1.66 M(-71.2%) | -$30.75 M(-9.6%) |
| Mar 2024 | - | -$5.75 M(-63.0%) | -$34.00 M(+6.5%) |
| Dec 2023 | -$31.92 M(+60.2%) | -$15.53 M(+98.7%) | -$31.92 M(+45.5%) |
| Sept 2023 | - | -$7.82 M(+59.2%) | -$21.94 M(+6.3%) |
| June 2023 | - | -$4.91 M(+34.1%) | -$20.65 M(+0.3%) |
| Mar 2023 | - | -$3.66 M(-34.1%) | -$20.59 M(+2.5%) |
| Dec 2022 | -$19.92 M(+4.5%) | -$5.56 M(-14.8%) | -$20.08 M(-1.4%) |
| Sept 2022 | - | -$6.52 M(+34.4%) | -$20.37 M(+15.4%) |
| June 2022 | - | -$4.85 M(+53.9%) | -$17.66 M(-5.4%) |
| Mar 2022 | - | -$3.15 M(-46.1%) | -$18.66 M(-2.0%) |
| Dec 2021 | -$19.06 M(+38.8%) | -$5.85 M(+53.6%) | -$19.04 M(+11.5%) |
| Sept 2021 | - | -$3.81 M(-35.0%) | -$17.07 M(+3.3%) |
| June 2021 | - | -$5.86 M(+66.0%) | -$16.52 M(+19.8%) |
| Mar 2021 | - | -$3.53 M(-9.0%) | -$13.78 M(+0.3%) |
| Dec 2020 | -$13.73 M(+52.9%) | -$3.88 M(+19.2%) | -$13.74 M(+24.5%) |
| Sept 2020 | - | -$3.25 M(+4.3%) | -$11.04 M(+4.7%) |
| June 2020 | - | -$3.12 M(-10.5%) | -$10.54 M(+12.7%) |
| Mar 2020 | - | -$3.49 M(+197.2%) | -$9.35 M(+4.1%) |
| Dec 2019 | -$8.98 M(-3.7%) | -$1.17 M(-57.4%) | -$8.98 M(-2.2%) |
| Sept 2019 | - | -$2.75 M(+42.2%) | -$9.18 M(-2.7%) |
| June 2019 | - | -$1.94 M(-37.9%) | -$9.44 M(-4.3%) |
| Mar 2019 | - | -$3.12 M(+127.5%) | -$9.86 M(+5.9%) |
| Dec 2018 | -$9.32 M(+14.8%) | -$1.37 M(-54.4%) | -$9.31 M(-5.6%) |
| Sept 2018 | - | -$3.01 M(+27.5%) | -$9.87 M(+22.4%) |
| June 2018 | - | -$2.36 M(-8.3%) | -$8.06 M(+2.4%) |
| Mar 2018 | - | -$2.57 M(+33.8%) | -$7.87 M(-3.0%) |
| Dec 2017 | -$8.12 M(+8.2%) | -$1.92 M(+60.2%) | -$8.12 M(+10.2%) |
| Sept 2017 | - | -$1.20 M(-44.8%) | -$7.37 M(-18.4%) |
| June 2017 | - | -$2.17 M(-22.9%) | -$9.03 M(+10.7%) |
| Mar 2017 | - | -$2.82 M(+140.5%) | -$8.16 M(-9.5%) |
| Dec 2016 | -$7.50 M(-50.7%) | -$1.17 M(-59.0%) | -$9.02 M(-17.9%) |
| Sept 2016 | - | -$2.86 M(+119.6%) | -$10.98 M(-7.9%) |
| June 2016 | - | -$1.30 M(-64.6%) | -$11.92 M(-22.9%) |
| Mar 2016 | - | -$3.68 M(+17.3%) | -$15.46 M(+1.5%) |
| Dec 2015 | -$15.23 M(-12.7%) | -$3.14 M(-17.5%) | -$15.23 M(-8.0%) |
| Sept 2015 | - | -$3.80 M(-21.5%) | -$16.54 M(-2.3%) |
| June 2015 | - | -$4.84 M(+40.7%) | -$16.94 M(-0.6%) |
| Mar 2015 | - | -$3.44 M(-22.7%) | -$17.05 M(-2.2%) |
| Dec 2014 | -$17.44 M(+7.6%) | -$4.45 M(+6.1%) | -$17.44 M(+7.8%) |
| Sept 2014 | - | -$4.20 M(-15.2%) | -$16.18 M(-5.5%) |
| June 2014 | - | -$4.95 M(+29.2%) | -$17.11 M(+4.1%) |
| Mar 2014 | - | -$3.83 M(+20.0%) | -$16.44 M(+1.4%) |
| Dec 2013 | -$16.21 M(-6.5%) | -$3.19 M(-37.8%) | -$16.21 M(-12.2%) |
| Sept 2013 | - | -$5.13 M(+20.0%) | -$18.47 M(-7.3%) |
| June 2013 | - | -$4.28 M(+18.6%) | -$19.92 M(+6.9%) |
| Mar 2013 | - | -$3.61 M(-33.9%) | -$18.64 M(+7.6%) |
| Dec 2012 | -$17.33 M(+93.1%) | -$5.45 M(-17.1%) | -$17.33 M(+15.8%) |
| Sept 2012 | - | -$6.58 M(+119.4%) | -$14.97 M(+34.6%) |
| June 2012 | - | -$3.00 M(+30.6%) | -$11.12 M(+6.8%) |
| Mar 2012 | - | -$2.30 M(-25.8%) | -$10.41 M(+16.0%) |
| Dec 2011 | -$8.97 M(-31.6%) | -$3.10 M(+13.3%) | -$8.97 M(+7.1%) |
| Sept 2011 | - | -$2.73 M(+19.4%) | -$8.38 M(-11.6%) |
| June 2011 | - | -$2.29 M(+166.0%) | -$9.48 M(+10.1%) |
| Mar 2011 | - | -$860.00 K(-65.6%) | -$8.61 M(-34.4%) |
| Dec 2010 | -$13.13 M(-1.0%) | -$2.50 M(-34.9%) | -$13.13 M(-10.1%) |
| Sept 2010 | - | -$3.83 M(+170.7%) | -$14.60 M(+10.4%) |
| June 2010 | - | -$1.42 M(-73.7%) | -$13.23 M(-16.2%) |
| Mar 2010 | - | -$5.38 M(+35.4%) | -$15.79 M(+19.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$13.26 M(+3.5%) | -$3.97 M(+61.7%) | -$13.26 M(+8.1%) |
| Sept 2009 | - | -$2.46 M(-38.2%) | -$12.28 M(-7.5%) |
| June 2009 | - | -$3.98 M(+39.5%) | -$13.27 M(+6.8%) |
| Mar 2009 | - | -$2.85 M(-4.4%) | -$12.42 M(-3.1%) |
| Dec 2008 | -$12.81 M(-33.6%) | -$2.98 M(-13.5%) | -$12.81 M(-7.4%) |
| Sept 2008 | - | -$3.45 M(+10.3%) | -$13.84 M(-16.5%) |
| June 2008 | - | -$3.13 M(-3.5%) | -$16.57 M(-5.8%) |
| Mar 2008 | - | -$3.25 M(-19.1%) | -$17.59 M(-8.8%) |
| Dec 2007 | -$19.29 M(+3.2%) | -$4.01 M(-35.1%) | -$19.29 M(-2.1%) |
| Sept 2007 | - | -$6.18 M(+48.6%) | -$19.70 M(+13.3%) |
| June 2007 | - | -$4.16 M(-15.8%) | -$17.38 M(-3.7%) |
| Mar 2007 | - | -$4.94 M(+11.8%) | -$18.05 M(-3.5%) |
| Dec 2006 | -$18.69 M(+88.5%) | -$4.42 M(+14.4%) | -$18.70 M(+7.6%) |
| Sept 2006 | - | -$3.86 M(-19.9%) | -$17.38 M(+10.6%) |
| June 2006 | - | -$4.83 M(-13.6%) | -$15.71 M(+17.5%) |
| Mar 2006 | - | -$5.59 M(+80.0%) | -$13.37 M(+34.8%) |
| Dec 2005 | -$9.91 M(-8.9%) | -$3.10 M(+41.5%) | -$9.92 M(+14.1%) |
| Sept 2005 | - | -$2.19 M(-11.7%) | -$8.69 M(-5.7%) |
| June 2005 | - | -$2.48 M(+16.3%) | -$9.21 M(+3.2%) |
| Mar 2005 | - | -$2.13 M(+13.6%) | -$8.92 M(-18.1%) |
| Dec 2004 | -$10.89 M(+50.2%) | -$1.88 M(-30.7%) | -$10.89 M(-3.4%) |
| Sept 2004 | - | -$2.71 M(+23.6%) | -$11.27 M(+9.2%) |
| June 2004 | - | -$2.19 M(-46.5%) | -$10.32 M(+5.7%) |
| Mar 2004 | - | -$4.10 M(+81.6%) | -$9.76 M(+34.6%) |
| Dec 2003 | -$7.25 M(+9.5%) | -$2.26 M(+27.9%) | -$7.25 M(+15.8%) |
| Sept 2003 | - | -$1.77 M(+7.9%) | -$6.26 M(-1.8%) |
| June 2003 | - | -$1.64 M(+2.8%) | -$6.38 M(-4.9%) |
| Mar 2003 | - | -$1.59 M(+25.7%) | -$6.70 M(+1.3%) |
| Dec 2002 | -$6.62 M(-24.8%) | -$1.27 M(-32.7%) | -$6.62 M(-5.7%) |
| Sept 2002 | - | -$1.88 M(-4.1%) | -$7.02 M(-4.2%) |
| June 2002 | - | -$1.96 M(+30.2%) | -$7.32 M(-5.7%) |
| Mar 2002 | - | -$1.51 M(-9.4%) | -$7.76 M(-11.8%) |
| Dec 2001 | -$8.80 M(-2.7%) | -$1.66 M(-23.9%) | -$8.80 M(-9.0%) |
| Sept 2001 | - | -$2.19 M(-9.0%) | -$9.68 M(-0.0%) |
| June 2001 | - | -$2.40 M(-5.7%) | -$9.68 M(+2.2%) |
| Mar 2001 | - | -$2.55 M(+0.5%) | -$9.47 M(+4.7%) |
| Dec 2000 | -$9.04 M(-29.2%) | -$2.54 M(+16.0%) | -$9.04 M(-22.3%) |
| Sept 2000 | - | -$2.19 M(-0.3%) | -$11.64 M(+1.4%) |
| June 2000 | - | -$2.19 M(+3.3%) | -$11.48 M(-4.2%) |
| Mar 2000 | - | -$2.12 M(-58.6%) | -$11.99 M(-6.6%) |
| Dec 1999 | -$12.78 M(+77.5%) | -$5.13 M(+152.7%) | -$12.83 M(+33.7%) |
| Sept 1999 | - | -$2.03 M(-24.7%) | -$9.60 M(+3.6%) |
| June 1999 | - | -$2.70 M(-9.0%) | -$9.27 M(+12.1%) |
| Mar 1999 | - | -$2.97 M(+56.3%) | -$8.27 M(+19.8%) |
| Dec 1998 | -$7.20 M(+12.5%) | -$1.90 M(+11.7%) | -$6.90 M(+4.5%) |
| Sept 1998 | - | -$1.70 M(0.0%) | -$6.60 M(+3.1%) |
| June 1998 | - | -$1.70 M(+6.3%) | -$6.40 M(+10.3%) |
| Mar 1998 | - | -$1.60 M(0.0%) | -$5.80 M(-12.1%) |
| Dec 1997 | -$6.40 M(+33.3%) | -$1.60 M(+6.7%) | -$6.60 M(+3.1%) |
| Sept 1997 | - | -$1.50 M(+36.4%) | -$6.40 M(0.0%) |
| June 1997 | - | -$1.10 M(-54.2%) | -$6.40 M(+1.6%) |
| Mar 1997 | - | -$2.40 M(+71.4%) | -$6.30 M(+37.0%) |
| Dec 1996 | -$4.80 M(+380.0%) | -$1.40 M(-6.7%) | -$4.60 M(-27.0%) |
| Sept 1996 | - | -$1.50 M(+50.0%) | -$6.30 M(+53.7%) |
| June 1996 | - | -$1.00 M(+42.9%) | -$4.10 M(+70.8%) |
| Mar 1996 | - | -$700.00 K(-77.4%) | -$2.40 M(+140.0%) |
| Dec 1995 | -$1.00 M | -$3.10 M(-542.9%) | -$1.00 M(-147.6%) |
| Sept 1995 | - | $700.00 K(0.0%) | $2.10 M(+50.0%) |
| June 1995 | - | $700.00 K(0.0%) | $1.40 M(+100.0%) |
| Mar 1995 | - | $700.00 K | $700.00 K |
FAQ
- What is AIM ImmunoTech annual earnings before interest & taxes?
- What is the all time high annual EBIT for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly EBIT year-on-year change?
- What is AIM ImmunoTech TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for AIM ImmunoTech?
- What is AIM ImmunoTech TTM EBIT year-on-year change?
What is AIM ImmunoTech annual earnings before interest & taxes?
The current annual EBIT of AIM is -$31.92 M
What is the all time high annual EBIT for AIM ImmunoTech?
AIM ImmunoTech all-time high annual earnings before interest & taxes is $2.07 M
What is AIM ImmunoTech quarterly earnings before interest & taxes?
The current quarterly EBIT of AIM is -$3.50 M
What is the all time high quarterly EBIT for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly earnings before interest & taxes is $700.00 K
What is AIM ImmunoTech quarterly EBIT year-on-year change?
Over the past year, AIM quarterly earnings before interest & taxes has changed by +$12.03 M (+77.48%)
What is AIM ImmunoTech TTM earnings before interest & taxes?
The current TTM EBIT of AIM is -$26.43 M
What is the all time high TTM EBIT for AIM ImmunoTech?
AIM ImmunoTech all-time high TTM earnings before interest & taxes is $2.10 M
What is AIM ImmunoTech TTM EBIT year-on-year change?
Over the past year, AIM TTM earnings before interest & taxes has changed by +$5.49 M (+17.19%)